APA

Mehta Shantanu, University of Delhi. Faculty of Medical Sciences. Department of Pharmacology, Dr. Kamlesh Kohli Gu, Dr. Naresh Gupta Gu & University of Delhi. Faculty of Medical Sciences. Department of Pharmacology. (2005). To compare the effects of add-on HMG-COA reductase inhibitors (Rosuvastatin and atorvastatin) on extended plasma lipid profile and oxidative markers in hypertensive dyslipidemic patients on ace inhibitor therapy. : .

Chicago

Mehta Shantanu, University of Delhi. Faculty of Medical Sciences. Department of Pharmacology, Dr. Kamlesh Kohli Gu, Dr. Naresh Gupta Gu and University of Delhi. Faculty of Medical Sciences. Department of Pharmacology. 2005. To compare the effects of add-on HMG-COA reductase inhibitors (Rosuvastatin and atorvastatin) on extended plasma lipid profile and oxidative markers in hypertensive dyslipidemic patients on ace inhibitor therapy. : .

Harvard

Mehta Shantanu, University of Delhi. Faculty of Medical Sciences. Department of Pharmacology, Dr. Kamlesh Kohli Gu, Dr. Naresh Gupta Gu and University of Delhi. Faculty of Medical Sciences. Department of Pharmacology. (2005). To compare the effects of add-on HMG-COA reductase inhibitors (Rosuvastatin and atorvastatin) on extended plasma lipid profile and oxidative markers in hypertensive dyslipidemic patients on ace inhibitor therapy. : .

MLA

Mehta Shantanu, University of Delhi. Faculty of Medical Sciences. Department of Pharmacology, Dr. Kamlesh Kohli Gu, Dr. Naresh Gupta Gu and University of Delhi. Faculty of Medical Sciences. Department of Pharmacology. To compare the effects of add-on HMG-COA reductase inhibitors (Rosuvastatin and atorvastatin) on extended plasma lipid profile and oxidative markers in hypertensive dyslipidemic patients on ace inhibitor therapy. : . 2005.